Various signaling molecules within the TME, including TGF-β, ROS, inflammatory cytokines, contact signals, and receptor tyrosine kinase (RTK) ligands, trigger the conversion of fibroblasts into activated cancer-associated fibroblasts (CAFs) that exhibit significant heterogeneity and plasticity [333,334]. The gene discussed is TGFB1; the disease is cancer.